Search research articles
Contact Us
Filters
Showing results (81-90 of 100) with videos related to
Page
of 10
Sort By:
Current Medical Research and Opinion
|
May 15, 2023
Applying the good publication practice 2022 guidelines in the Asia-Pacific region: a practical guide
Blair R Hesp, Katsuhisa Arai, Namita Bose, et al.
Lancet (London, England)
|
May 15, 1976
Anabolic effect of low doses of a fragment of human parathyroid hormone on the skeleton in postmenopausal osteoporosis
J Reeve, R Hesp, D Williams, et al.
Clinical Science (London, England : 1979)
|
July 1, 1979
Fractured neck of femur in the elderly: an attempt to identify patients at risk
R Wootton, P J Brereton, M B Clark, et al.
Arthritis and Rheumatism
|
May 1, 1990
Rapid periarticular bone loss in rheumatoid arthritis. Possible promotion by normal circulating concentrations of parathyroid hormone or calcitriol (1,25-dihydroxyvitamin D3)
P N Sambrook, D Shawe, R Hesp, et al.
Age and Ageing
|
August 1, 1982
Risk factors for fractured neck of femur in the elderly
R Wootton, E Bryson, U Elsasser, et al.
Bone and Mineral
|
June 1, 1992
Bone remodelling does not decline after menopause in vertebral fracture osteoporosis
J S Wand, J R Green, R Hesp, et al.
Research Integrity and Peer Review
|
October 9, 2019
A guide to applying the Good Publication Practice 3 guidelines in the Asia-Pacific region
Blair R Hesp, Katsuhisa Arai, Magdalene Y S Chu, et al.
Acta Paediatrica Scandinavica. Supplement
|
January 1, 1991
Growth hormone therapy in adults with growth hormone deficiency
P H Sönksen, R C Cuneo, F Salomon, et al.
BMJ (Clinical Research Ed.)
|
July 2, 1988
Dietary intake of calcium and postmenopausal bone loss
J C Stevenson, M I Whitehead, M Padwick, et al.
European Journal of Clinical Investigation
|
October 1, 1987
Periodic courses of human 1-34 parathyroid peptide alternating with calcitriol paradoxically reduce bone remodelling in spinal osteoporosis
J Reeve, M Arlot, T R Price, et al.
Page
of 10
Search research articles
Search
Showing results (81-90 of 100) with videos related to
Sort By:
Page
of 10
Current Medical Research and Opinion
|
May 15, 2023
Applying the good publication practice 2022 guidelines in the Asia-Pacific region: a practical guide
Blair R Hesp, Katsuhisa Arai, Namita Bose, et al.
Lancet (London, England)
|
May 15, 1976
Anabolic effect of low doses of a fragment of human parathyroid hormone on the skeleton in postmenopausal osteoporosis
J Reeve, R Hesp, D Williams, et al.
Clinical Science (London, England : 1979)
|
July 1, 1979
Fractured neck of femur in the elderly: an attempt to identify patients at risk
R Wootton, P J Brereton, M B Clark, et al.
Arthritis and Rheumatism
|
May 1, 1990
Rapid periarticular bone loss in rheumatoid arthritis. Possible promotion by normal circulating concentrations of parathyroid hormone or calcitriol (1,25-dihydroxyvitamin D3)
P N Sambrook, D Shawe, R Hesp, et al.
Age and Ageing
|
August 1, 1982
Risk factors for fractured neck of femur in the elderly
R Wootton, E Bryson, U Elsasser, et al.
Bone and Mineral
|
June 1, 1992
Bone remodelling does not decline after menopause in vertebral fracture osteoporosis
J S Wand, J R Green, R Hesp, et al.
Research Integrity and Peer Review
|
October 9, 2019
A guide to applying the Good Publication Practice 3 guidelines in the Asia-Pacific region
Blair R Hesp, Katsuhisa Arai, Magdalene Y S Chu, et al.
Acta Paediatrica Scandinavica. Supplement
|
January 1, 1991
Growth hormone therapy in adults with growth hormone deficiency
P H Sönksen, R C Cuneo, F Salomon, et al.
BMJ (Clinical Research Ed.)
|
July 2, 1988
Dietary intake of calcium and postmenopausal bone loss
J C Stevenson, M I Whitehead, M Padwick, et al.
European Journal of Clinical Investigation
|
October 1, 1987
Periodic courses of human 1-34 parathyroid peptide alternating with calcitriol paradoxically reduce bone remodelling in spinal osteoporosis
J Reeve, M Arlot, T R Price, et al.
Page
of 10